Search results
Results from the WOW.Com Content Network
As a result, the minimum infective dose is exactly equal to one bacterial cell, deviating from the traditional notion of the MID. Proportionality has a second consequence: when the dose is divided by ten, the probability of observing the effect is also divided by ten. Additionally, it is a relationship without threshold.
In epidemiology, infectivity is the ability of a pathogen to establish an infection. More specifically, infectivity is the extent to which the pathogen can enter, survive, and multiply in a host. It is measured by the ratio of the number of people who become infected to the total number exposed to the pathogen. [1]
The TCID 50 (50% tissue culture infectious dose) assay is the measure of infectious virus titer. This endpoint dilution assay quantifies the amount of virus required to kill 50% of infected hosts or to produce a cytopathic effect in 50% of inoculated tissue culture cells. This assay may be more common in clinical research applications where the ...
This quantity determines whether the infection will increase sub-exponentially, die out, or remain constant: if R 0 > 1, then each person on average infects more than one other person so the disease will spread; if R 0 < 1, then each person infects fewer than one person on average so the disease will die out; and if R 0 = 1, then each person ...
The serial interval in the epidemiology of communicable (infectious) diseases is the time between successive cases in a chain of transmission. [1]The serial interval is generally estimated from the interval between clinical onsets (if observable), in which case it is the 'clinical onset serial interval'.
A 2010 review study by Puren et al. [2] categorizes viral load testing into three types: (1) nucleic acid amplification based tests (NATs or NAATs) commercially available in the United States with Food and Drug Administration (FDA) approval, or on the market in the European Economic Area (EEA) with the CE marking; (2) "Home–brew" or in-house NATs; (3) non-nucleic acid-based test.
When developing vaccines for viruses, the emphasis is on attenuating the virus, or decreasing its virulence, in a given host. Sometimes it is useful to employ serial passage to increase the virulence of a virus. Usually, when serial passage is performed in a species, the result is a virus that is more virulent to that species. [5]
A viral infection does not always cause disease. A viral infection simply involves viral replication in the host, but disease is the damage caused by viral multiplication. [5] An individual who has a viral infection but does not display disease symptoms is known as a carrier. [17] Mechanisms by which viruses cause damage and disease to host cells